These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 10333347

  • 21. Efficacy and safety of 30-mg fimasartan for the treatment of patients with mild to moderate hypertension: an 8-week, multicenter, randomized, double-blind, phase III clinical study.
    Youn JC, Ihm SH, Bae JH, Park SM, Jeon DW, Jung BC, Park TH, Lee NH, Song JM, Yoon YW, Shin ES, Sung KC, Jung IH, Pyun WB, Joo SJ, Park WJ, Shin JH, Kang SM.
    Clin Ther; 2014 Oct 01; 36(10):1412-21. PubMed ID: 25092393
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial.
    Oparil S, Yarows SA, Patel S, Fang H, Zhang J, Satlin A.
    Lancet; 2007 Jul 21; 370(9583):221-229. PubMed ID: 17658393
    [Abstract] [Full Text] [Related]

  • 23. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril.
    Holwerda NJ, Fogari R, Angeli P, Porcellati C, Hereng C, Oddou-Stock P, Heath R, Bodin F.
    J Hypertens; 1996 Sep 21; 14(9):1147-51. PubMed ID: 8986917
    [Abstract] [Full Text] [Related]

  • 24. Sustained antihypertensive activity of telmisartan compared with valsartan.
    Lacourcière Y, Krzesinski JM, White WB, Davidai G, Schumacher H.
    Blood Press Monit; 2004 Aug 21; 9(4):203-10. PubMed ID: 15311147
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients.
    Krum H, Nolly H, Workman D, He W, Roniker B, Krause S, Fakouhi K.
    Hypertension; 2002 Aug 21; 40(2):117-23. PubMed ID: 12154100
    [Abstract] [Full Text] [Related]

  • 30. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial.
    Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayastha D, Lacourcière Y, Hippler SE, Fields H, Naqvi TZ, Mulvagh SL, Arnold JM, Thomas JD, Zile MR, Aurigemma GP, Valsartan In Diastolic Dysfunction (VALIDD) Investigators.
    Lancet; 2007 Jun 23; 369(9579):2079-87. PubMed ID: 17586303
    [Abstract] [Full Text] [Related]

  • 31. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension.
    White WB, Weber MA, Sica D, Bakris GL, Perez A, Cao C, Kupfer S.
    Hypertension; 2011 Mar 23; 57(3):413-20. PubMed ID: 21282560
    [Abstract] [Full Text] [Related]

  • 32. A multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination versus amlodipine in patients with mild to moderate hypertension.
    Palatini P, Malacco E, Fogari R, Carretta R, Bonaduce D, Bertocchi F, Mann J, Condorelli M, Italian Collaborative Study Group.
    J Hypertens; 2001 Sep 23; 19(9):1691-6. PubMed ID: 11564991
    [Abstract] [Full Text] [Related]

  • 33. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan 23; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 34. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    McGill JB, Reilly PA.
    Clin Ther; 2001 Jun 23; 23(6):833-50. PubMed ID: 11440284
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies.
    Lee H, Yang HM, Lee HY, Kim JJ, Choi DJ, Seung KB, Jeon ES, Ha JW, Rim SJ, Park JB, Shin JH, Oh BH.
    Clin Ther; 2012 Jun 23; 34(6):1273-89. PubMed ID: 22608107
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H, Ogihara T, Miyata Y, Sasai K, Totsuka N.
    Clin Ther; 2012 Apr 23; 34(4):838-48. PubMed ID: 22440192
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Trough:peak ratio and smoothness index in the evaluation of 24-h blood pressure control in hypertension: a comparative study between valsartan/hydrochlorothiazide combination and amlodipine.
    Palatini P, Malacco E, Di SS, Carretta R, Dorigatti F, Bertocchi F, Mann J.
    Eur J Clin Pharmacol; 2002 Jan 23; 57(11):765-70. PubMed ID: 11868797
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.